Rapport TherapeuticsRAPP -0.60%14 Market Cap is $1,998.69 Mil as of Jul. 10, 2026. GuruFocus rates RAPP with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 1,422 Biotechnology companies, Rapport Therapeutics ranks better than 87.62% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Rapport Therapeutics's share price for the quarter that ended in Mar. 2026 was $31.29. Rapport Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 47.81 Mil. Therefore, Rapport Therapeutics's market cap for the quarter that ended in Mar. 2026 was $1,495.88 Mil.
Rapport Therapeutics's quarterly market cap
increased
from Sep. 2025 ($1,415.21 Mil) to Dec. 2025 ($1,449.43 Mil) and
increased
from Dec. 2025 ($1,449.43 Mil) to Mar. 2026 ($1,495.88 Mil).
Rapport Therapeutics's annual market cap
increased
from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($648.93 Mil) and
increased
from Dec. 2024 ($648.93 Mil) to Dec. 2025 ($1,449.43 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Rapport Therapeutics's Enterprise Value for Today is $1,530.80 Mil.
Rapport Therapeutics (NAS:RAPP) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Rapport Therapeutics Market Cap Related Terms
Rapport Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Rapport Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Rapport Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rapport Therapeutics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Rapport Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Rapport Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Rapport Therapeutics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rapport Therapeutics (RAPP) has a Market Cap of $1,998.69 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rapport Therapeutics and its competitors. According to the industry distribution chart, Rapport Therapeutics ranks #176 out of 1422 companies in the Biotechnology industry, placing it in the top 12.4%.
Is Rapport Therapeutics' Market Cap too high?
Rapport Therapeutics' current Market Cap is $1,998.69 Mil. The Biotechnology industry median Market Cap is 120.54. Rapport Therapeutics' value of $1,998.69 Mil is 1558.2% above this industry median. Based on the distribution chart, Rapport Therapeutics ranks #176 out of 1422 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Rapport Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Rapport Therapeutics' Market Cap compare to SION and TYRA?
According to the Biotechnology industry distribution chart, Rapport Therapeutics ranks #176 out of 1422 companies for Market Cap. This places Rapport Therapeutics in the top 12% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.54. Rapport Therapeutics' value of $1,998.69 Mil is 1558.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 120.54, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rapport Therapeutics's current Market Cap of $1,998.69 Mil is 1558.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Rapport Therapeutics and its competitors. For the Biotechnology industry, the median Market Cap is 120.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapport Therapeutics's current Market Cap is $1,998.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapport Therapeutics stock overvalued right now?
Rapport Therapeutics (RAPP) has a current Market Cap of $1,998.69 Mil. The current Market Cap is $1,998.69 Mil and 1558.2% above the Biotechnology industry median of 120.54. Rapport Therapeutics' overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Rapport Therapeutics (RAPP), the current Market Cap is $1,998.69 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
14GF Score
Get the complete analysis for RAPP
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RAPP has been successfully added to your 
